RPG Life Sciences Overview
- Year Founded
-
1968
- Status
-
Public
- Employees
-
1,288
- Stock Symbol
-
RPGLIFE
- Investments
-
2
- Share Price
-
$27.23
- (As of Friday Closing)
RPG Life Sciences General Information
Description
RPG Life Sciences Ltd is engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). The company is exclusively engaged in the pharmaceutical business and operates across Domestic Formulations, International Formulations, and Active Pharmaceutical Ingredients (API). It offers a range of high-value synthetic APIs in the general therapeutic category, with a growing product portfolio covering immunosuppressants, antipsychotics, anti-anginal, anthelmintics, anti-convulsant, anti-spasmodic, and other therapeutic categories. The company has a presence in Europe, Latin America, and Asia, and is making forays into the US markets. It has one reportable business segment, Pharmaceuticals.
Contact Information
Website
www.rpglifesciences.comCorporate Office
- RPG House, 463
- Doctor Annie Besant Road Worli
- Mumbai, 400030
- India
Corporate Office
- RPG House, 463
- Doctor Annie Besant Road Worli
- Mumbai, 400030
- India
RPG Life Sciences Stock Performance
As of 20-Nov-2026, RPG Life Sciences’s stock price is $27.23. Its current market cap is $450M with 16.5M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $27.23 | $27.88 | $18.50 - $32.56 | $450M | 16.5M | 25.6K | $0.72 |
RPG Life Sciences Financials Summary
As of 30-Sep-2026, RPG Life Sciences has a trailing 12-month revenue of $82.4M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 496,474 | 301,831 | 428,222 | 290,867 |
| Revenue | 82,426 | 79,444 | 76,580 | 69,756 |
| EBITDA | 18,712 | 18,888 | 29,769 | 16,179 |
| Net Income | 11,778 | 13,034 | 21,671 | 10,589 |
| Total Assets | 116,230 | 84,063 | 76,901 | 61,500 |
| Total Debt | 2,753 | 2,120 | 0 | 0 |
RPG Life Sciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
RPG Life Sciences Patents
RPG Life Sciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20150112059-A1 | Process for the preparation of a benzazepine derivative | Active | 21-Oct-2013 | ||
| US-9428461-B2 | Process for the preparation of a benzazepine derivative | Inactive | 21-Oct-2013 | ||
| WO-2012137216-A1 | A novel pharmaceutical formulation of alpha ketoanalogue of amino acids and additional amino acids for treatment of chronic kidney disease and method of preparation thereof | Inactive | 06-Apr-2011 | ||
| WO-2011125069-A1 | A process for preparation of crystalline form i of clopidogrel bisulfate | Inactive | 22-Mar-2010 | ||
| WO-2011128910-A2 | A drug delivery solid dosage formulation of sirolimus | Inactive | 02-Mar-2010 | A61K9/205 |
RPG Life Sciences Signals
RPG Life Sciences Investments & Acquisitions (2)
RPG Life Sciences’s most recent deal was a Corporate Asset Purchase with Sun Pharmaceutical Industries (Seven Prescription Brands) for . The deal was made on 27-Jul-2016.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries (Seven Prescription Brands) | 27-Jul-2016 | Corporate Asset Purchase | Buildings and Property | ||
| Brabourne Enterprises | 02-Apr-2007 | Merger/Acquisition | Pharmaceuticals |
RPG Life Sciences ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
RPG Life Sciences Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| RPG Active Pharma | Mumbai, India |
RPG Life Sciences FAQs
-
When was RPG Life Sciences founded?
RPG Life Sciences was founded in 1968.
-
Where is RPG Life Sciences headquartered?
RPG Life Sciences is headquartered in Mumbai, India.
-
What is the size of RPG Life Sciences?
RPG Life Sciences has 1,288 total employees.
-
What industry is RPG Life Sciences in?
RPG Life Sciences’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is RPG Life Sciences a private or public company?
RPG Life Sciences is a Public company.
-
What is RPG Life Sciences’s stock symbol?
The ticker symbol for RPG Life Sciences is RPGLIFE.
-
What is the current stock price of RPG Life Sciences?
As of 20-Nov-2026 the stock price of RPG Life Sciences is $27.23.
-
What is the current market cap of RPG Life Sciences?
The current market capitalization of RPG Life Sciences is $450M.
-
What is RPG Life Sciences’s current revenue?
The trailing twelve month revenue for RPG Life Sciences is $82.4M.
-
What is RPG Life Sciences’s annual earnings per share (EPS)?
RPG Life Sciences’s EPS for 12 months was $0.72.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process